| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |